Table 6.
Non-TC (n = 9) | TC (n = 7) | HC (n = 14) | Non-TC vs. HC, p | Non-TC vs. TC, p | TC vs. HC, p | |
---|---|---|---|---|---|---|
Crystallized composite | −0.17 | −0.49 | − 0.33 | 0.96 | 0.92 | 0.96 |
Fluid composite | −4.23 | 6.67 | 5.86 | 0.04 | 0.06 | 0.88 |
Total composite | − 2.94 | 1.58 | 3.63 | 0.12 | 0.35 | 0.64 |
Dimensional change card sort | −1.99 | 4.94 | 5.13 | 0.11 | 0.19 | 0.97 |
Flanker inhibitory control | −5.29 | −0.69 | 2.82 | 0.07 | 0.38 | 0.46 |
Working memory | 5.31 | 5.90 | 4.83 | 0.93 | 0.93 | 0.85 |
Oral reading recognition | −1.22 | −6.94 | 0.09 | 0.62 | 0.07 | 0.02 |
Processing speed | −6.17 | 7.59 | −1.45 | 0.45 | 0.07 | 0.18 |
Episodic memory | −4.85 | 1.62 | 6.80 | 0.12 | 0.46 | 0.52 |
Picture vocabulary | −0.05 | 7.46 | −1.48 | 0.68 | 0.08 | 0.02 |
Picture vocabulary | −0.05 | 7.46 | −1.48 | 0.68 | 0.08 | 0.02 |
The TC subgroup (n = 7) included the patients on the docetaxel and cyclophosphamide chemotherapy regimen. The non-TC subgroup (n = 9) included the patients on a chemotherapy regimen other than the TC regimen. Bold numbers indicate key findings